3,298 matches out of all 3,298, 2,641 to 2,670 displayed.
1948 | In 1948, staff of the Leonard Wood Memorial participated in the Vth International Congress on Leprosy in Havana, Cuba; 226 leprologists attended from 40 countries "Appendix 1 Important Dates and Events in the Scientific Program of the Leonard Wood Memorial" in Forty Years of Leprosy Research: History of the Leonard Wood Memorial (American Leprosy Foundation) 1928 to 1967 by Esmond R Long (Washington DC: Office of the Medical Director, Leonard Wood Memorial, 1967) [Organisation] |
1948 | In 1948, Dr Doull was appointed the Medical Director of the Leonard Wood Memorial and Dr Wade became the Associate Medical Director "Appendix 1 Important Dates and Events in the Scientific Program of the Leonard Wood Memorial" in Forty Years of Leprosy Research: History of the Leonard Wood Memorial (American Leprosy Foundation) 1928 to 1967 by Esmond R Long (Washington DC: Office of the Medical Director, Leonard Wood Memorial, 1967) [Organisation] |
1948 | On Fantôme Island, in Queensland, “Sulphetrone treatment commenced in 1948. Difficulty was experienced in regard to dosage, but this has now been cut down as a result of the number of reactions and complications have lessened. This has led to greater co-operation by the patients. It is pleasing to note that the results obtained at Peel Island are paralleled at Fantôme, and it is anticipated in the next few weeks seven patients will be discharged.” (Vincent F B Lennon, Medical Officer in Charge, F Mahony, Superintendent “Leprosy”Health Department Annual Report extract: 1949-50) [Epidemiology] [Australasia] |
1948 | Government expended £4,500 capital and £1,000 for maintenance. Their out-patients numbered 576, a very small proportion of the Protectorate cases, as the section on survey and incidence estimates will show (Anti-Leprosy Measures in the Uganda Protectorate, 1824-51) in “Leprosy Incidence and Control in East Africa, 1924-1952 and the Outlook” by Leonard Rogers, Leprosy Review 25.1 (1954): 41-59 [Epidemiology, Treatment, Organisation, People] [Africa, Uganda] |
1948 | Uganda: In 1948 Dr Wheate introduced sulphone treatment at Kumi, Uganda. [Treatment] [Africa, Uganda] |
1948 | Kenya: In Kenya, in 1948, only 291 cases were under treatment. A survey was due to be carried out, and it was reported that Colonial Development Funds were available, but sulphones had not yet been obtained. (Leonard Rogers, "Leprosy Incidence and Control in East Africa, 1924-1952 and the Outlook" Leprosy Review 25.1 (1954): 41-59) [Epidemiology, People] [Africa, Kenya] |
1948 | In 1948, at the Fifth International Leprosy Congress, in Havana, a resolution was passed recommending that use of the word "leper" be abandoned. Stanley Stein writes this: "the Havana Congress agreed unanimously 'that the use of the term 'leper' in designation of the patient with leprosy be abandoned, and the person suffering from the disease be designated 'leprosy patient'". (Alone No Longer 331) [People, Conference/Congress] [Carville] |
1948 | Sungai BulohThe first trials with dapsone in Malaysia (1948-49) were carried out in this leprosarium. Trials of alternative drugs formed a major part of the investigations. A. Joshua-Raghavar, Leprosy in Malaysia: Past, Present and Future, ed. Dr K Rajagopalan (A Joshua-Raghavar: Sungai Buluh, Selangor, West Malaysia, 1983): 8-9 [Leprosarium] [Malaysia] |
1948 | JesushilfeAt the commencement of the War of Liberation (i.e. Israel’s War of Independence) the hospital housed 60-70- patients, mostly Arabs. The hospital remained in the Jewish section of the new city (Jerusalem). The Arab patients preferred to move to East Jerusalem together with the Deaconesses. Remaining in the hospital were 34 H.D. patients (26 Jews and 8 Arabs). In 1951, the hospital was sold to the Government of Israel and the Ministry of Health took over the management. The name was changed to the Hansen Hospital. Medical responsibility for the hospital was given to the dermatology Department of Hadassah in Jerusalem. After 1948, 283 patients immigrated to Israel, most of them from 11 countries. Treatment was free. Actually the building can accommodate 100 beds, but the average number of in-patients never arose above 30; the rest received ambulatory treatment. Nissim Levy, History of Medicine in the Holy Land : 1799-1948 (Hakibbutz Hameuchad Publishing House & the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel, 1998), translation by Professor Mark N. Lowenthal. [Leprosarium] [Palestine] |
1948 | Ongino Hospital"Those who have had the opportunity of hearing Mr Ndahura speak will not forget the clearness with which he referred to the great change that came with the arrival of the new medicine, the sulphones. Then patients began to come readily, and with hope of being cured. This change coincided with the coming of Dr Wheate to Ongino in November 1948. Soon afterwards it became possible to issue discharge certificates to patients "symptom free" of the disease. (122/3 Kumi and Ongino 1958-1960, Report from Dr J Maurice Lea, Archives of the Leprosy Mission International, Brentford). [Leprosarium] [Uganda] |
1948 | BamraThe Princely State of Bamra was acceded to India on 1 Jan 1948. [Leprosarium] [India] |
1949 | DDS for treatment in tablet form. Used by Dr R G Cochrane. Positive bacillary findings in contacts of LL cases – Figueredo and Desai (Dongre, ILA History Workshop, July 2000) [Treatment, People] |
1949 | In 1949, the headquarters for the Scientific Research Program (Office of the Medical Director) for the Leonard Wood Memorial was established by Dr Doull at 1832 M Street, NW Washington, DC "Appendix 1 Important Dates and Events in the Scientific Program of the Leonard Wood Memorial" in Forty Years of Leprosy Research: History of the Leonard Wood Memorial (American Leprosy Foundation) 1928 to 1967 by Esmond R Long (Washington DC: Office of the Medical Director, Leonard Wood Memorial, 1967) [Organisation] |
1949 | In 1949, Dr Fred C Kluth was appointed the Assistant Epidemiologist of the Memorial and began epidemiology research in Texas. This was continued until 1956. These studies renewed interest in leprosy on the part of health officers. In one large city of Texas, a clinic was established for examination and treatment "Appendix 1 Important Dates and Events in the Scientific Program of the Leonard Wood Memorial" in Forty Years of Leprosy Research: History of the Leonard Wood Memorial (American Leprosy Foundation) 1928 to 1967 by Esmond R Long (Washington DC: Office of the Medical Director, Leonard Wood Memorial, 1967) [Organisation] |
1949 | In 1949, Dr Clarke T Gray was appointed Biochemist of the Leonard Wood Memorial Research Laboratory, Harvard Medical School, Boston, Massachusetts "Appendix 1 Important Dates and Events in the Scientific Program of the Leonard Wood Memorial" in Forty Years of Leprosy Research: History of the Leonard Wood Memorial (American Leprosy Foundation) 1928 to 1967 by Esmond R Long (Washington DC: Office of the Medical Director, Leonard Wood Memorial, 1967) [Organisation] |
1949 | The annual report on leprosy in Queensland states that “The use of sulphone drugs has been continued with the good results obtained in previous years. Promin was the drug first used and this was followed by diasone. It is generally accepted that these two sulphones, together with sulphetrone, produce equally good results, but promin has been discarded, firstly as it is necessary to give it intravenously, but chiefly because it is more toxic than the other two.” “As the method of spread of Hansen’s disease has yet to be discovered, and because it is limited, it should be able to be eradicated with the isolation of infected persons and adequate follow up of contacts. I am of the opinion that our only hope of eradicating Hansen’s disease is by isolating patients and by sulphone drugs, and until such time as the method of spread of the disease is known I cannot recommend any alteration in the present policy of discharge.” [Epidemiology] [Australasia] |
1949 | Since the introduction of the sulphetrone drugs, Government expenditure has risen sharply. Dr.Ross Innes’s surveys have led to many requests for admission by leprosy cases, mostly advanced ones (Anti-Leprosy Measures in the Uganda Protectorate, 1824-51) in “Leprosy Incidence and Control in East Africa, 1924-1952 and the Outlook” by Leonard Rogers, Leprosy Review 25.1 (1954): 41-59 [Treatment, People, Organisation, Epidemiology] [Africa, Uganda] |
1949 | Kenya: In 1949, Dr. Ross Innes, after making a survey, reported 10.2 per mille, and estimated the total number of leprosy cases at 35,000 in Kenya. Most cases were non-infectious and could be treated at home. Preliminary plans for a leprosarium at Itesio were made for about 500 infective cases. Prior to 1949, the Kenya annual medical reports indicated little progress during the quarter of a century in the adoption of modern anti-leprosy measures. However, subsequently, the adoption of the more effective sulphone treatment, combined with the stimulus of Ross Innes’ surveys in revealing the serious incidence of leprosy in the Kenya Protectorate, led the Government to the conclusion that leprosy could be controlled, and possibly even eradicated, provided the necessary finance was available. "The results of Ross Innes’s survey revealed an approximate estimate of 35,000, or 10.2 per mille population. Infective lepromatous ones formed about 20 per cent of the total; this indicates a total of about 7,000 which require isolation to prevent further infections from them, and to permit them to receive efficient sulphone treatment. The urgency of providing leprosaria for this purpose is shown by the statement of Ross Innes that he had only found 50-60 cases under effective treatment and some 200 others in two camps. The incidence in different areas varied from 0.9 to 32.7 per mille. Overcrowding and high humidity again favoured high incidence. This indicates the necessity of seeking out dry localities for the new leprosaria. This is being done and in 1953 it was reported by BELRA that the new one at Itesio already had 2,500 registered patients, most of whom were out-patients coming from as far as 15 miles away for treatment." (Leonard Rogers, "Leprosy Incidence and Control in East Africa, 1924-1952 and the Outlook" Leprosy Review 25.1 (1954): 41-59) [Epidemiology, People] [Africa, Kenya] |
1949 | Thane District, Maharashtra, India: 38 cases were under treatment in asylums. Source: Maharashtra State Gazetteer: Government of Maharashtra Thane District (Revised Edition). Bombay: Gazetteers Department, Government of Maharashtra, 1982. 1st edn: 1882. 2nd edn (rev) 1982, p. 897. [Epidemiology] [India] |
1949 | St Joseph's Leprosy HospitalHospital founded by Mgr Francis T Roche, S J, with the help of three sisters of the Institute of Franciscan Missionaries of Mary (FMM). Leprosy Review, Sep 2000, 71.3 [Leprosarium] [India] |
1949 | Xiaowang Island leprosariumConstruction of the leprosarium began in Autumn 1949. Source: Professor Jiang Cheng (Compiler), "A Schedule of the Leprosy Hospitals and Clinics: Preliminary Investigation in China" Department for the Prevention of Epidemic Diseases, Ministry of Health, China (April 1951). [Leprosarium] [China] |
1950 | Indian Council of BELRA becomes HKNS. All the five-year plans provided budget for leprosy control work. (Dongre, ILA History Workshop, July 2000) [Organisation] [India] |
1950 | Indian Association of Leprologists (Dongre, ILA History Workshop, July 2000) [Other] [India] |
1950 | 1950s - National Leprosy Campaign (Campanha Nacional de Lepra) begun in Brazil. It ended in 1964. (Velloso, A P & Andrade, V. Hanseníase: curar para eliminar. Porto Alegre, 2002) [Other] [Brazil] |
1950 | On December 5, 1950, the Hatibari Health Home was established by Dr Santra. [People] [India] |
1950 | "Between 1950 and 1960, there were nineteen provinces, autonomous regions and municipalities with a prevalence of 1/10,000. These were Guangdong, Yunnan, Hainan, Tibet, Fujian, Guizhou, Jiangsu, Shangdong, Guangxi, Shanghai, Jiangxi, Qinghai, Shaanxi, Zhejiang, Xinjiang, Hubei, Gansu, Sichuan, and Huan." (Professor Yin Dakui, Vice Minister of Health, the People's Republic of China, "Achievements and Prospect on Leprosy Prevention and Control in China", September 7, 1998, Bejing) [Epidemiology] [China] |
1950 | "In the 1950s, due to the absence of effective treatment measures, leprosy was regarded as an "incurable disease". Owing to the limited number of leprosaria and the charity organisaations, as well as the shortage of financial resources and health care services, the majority of patients suffered from disability and did not have the means to support themselves. As a result, they went begging in the streets. They are cast out and isolated or even attempted to end their lives. The fear of the disease and discrimination against patients with leprosy was widespread." (Professor Yin Dakui, Vice Minister of Health, the People's Republic of China, "Achievements and Prospect on Leprosy Prevention and Control in China", September 7, 1998, Bejing) [Other] [China] |
1950 | From the 1950s through to the 1970s, in the Chinese countryside, where the incidence of leprosy was high, leprosy villages were built for housing and treatment with DDS. The government allocated land for such villages. Patients enjoyed free medical treatment provided by the health department. They also received financial subsidies from the Department of Civil Affairs." (Professor Yin Dakui, Vice Minister of Health, the People's Republic of China, "Achievements and Prospect on Leprosy Prevention and Control in China", September 7, 1998, Bejing) [Treatment] [China] |
1950 | “I must confess that we have all been misled in the past regarding the dimensions of the leprosy problem in China. Former estimates were based on approximations published in 1933 which were essentially extrapolations of incomplete and misleading data. We now know that the figure of 2.6 million cases for the whole of China was calculated on the basis of studies in the costal provinces and Yangtse River basin provinces, where the prevalence rates were higher. More reliable statistics are provided by the health authorities of the People’s Republic of the situation when the health services were extended, after the First and Second National Health Conferences in 1950 and 1951, to cover the whole country. Leprosy was then included in the countryside review. In accordance with the earlier accepted practice, the majority of leprosy sufferers actually receiving some care were inpatients in the forty institutions already mentioned. Official statistics indicate that there were about 50,000 people suffering from leprosy at the time, most of whom were receiving no treatment at all. (Stanley Browne, “Medical Services behind the Bamboo Curtain”, an unpublished paper given at the Eighteenth Meeting of the International Association of Physicians for the Overseas Services, Friday, November 27th, 1981.) [Epidemiology] [China] |
1950 | In 1950, the Leonard Wood Memorial sponsored the establishment of a Registry of Leprosy in the American Registry of Pathology, Armed Forces Institute of Pathology (AFIP), Washington DC in cooperation with the National Research Council, to supply teaching materials on leprosy to physicians and medical schools at home and abroad. A subsidy was made and has been continued annually "Appendix 1 Important Dates and Events in the Scientific Program of the Leonard Wood Memorial" in Forty Years of Leprosy Research: History of the Leonard Wood Memorial (American Leprosy Foundation) 1928 to 1967 by Esmond R Long (Washington DC: Office of the Medical Director, Leonard Wood Memorial, 1967) [Organisation] |